117
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Signaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia Cells

&
Pages 703-709 | Published online: 01 Jul 2009

  • Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. (1987) "Interferons and their actions", Annual Review of Biochemistry 56, 727-777.
  • Gutterman, J.U. (1994) "Cytokine therapeutics: lessons from interferon a", Proceedings of the national Academy of Sciences USA 91, 1198-1205.
  • Platanias, L.C. (1995) "Interferons. Laboratory to clinic investigations", Current Opinion in Oncology 7, 560-565.
  • Stark, G.R., Kerr, I.M., Williams, B. R.G., Silverman, R.H. and Screiber, R.D. (1998) "How cells respond to interferons", Annual Review of Biochemistry 67, 227-264.
  • The Italian Cooperative Study group on Chronic myeloid leukemia(1991) "Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia", New England Journal of Medicine 27, 53-57.
  • Groften, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R and Grosveld, G. (1984) "Philadelphia chromosomal breakpoints are clustered within a limited region. bcr, on chromosome 22", Cell 36, 93-99.
  • Daley, G.Q., Van Etten, R.A. and Baltimore, D (1990) "Blast crisis in a murine model of chronic myclogenous leukemia", Science 247, 824-830.
  • Lugo, T.C., Pendergast, A.M., Muller, A.J. and Witte, O.N. (1990) "Tyrosine kinase activity and transformation potency of bcr-abl oncogene products", Science 247, 1079-1082.
  • Kelliher, M.A., Mc Laughlin, J., Witte, O.N. and Rosenberg, A. (1990) "Induction of chronic myelogenous leykemia like syndrome in mice with v-abl and BCR-ABL", Proceedings of the National Academy of Sciences USA 87, 6649-6653.
  • Sawyers, C.L. (1999) "Chronic myeloid leukemia", New England Journal of Medicine 340, 1330-1340.
  • Kantarjian, H.M., O'Brien, S., Smith, T.L., Rios, M.B., Cortes, J., Beran, M., Koller, C., Giles, F.J., Andreeff, M., Kornblau, S., Giralt, S., Keating, M.J. and Talpaz, M. (1999) "Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine", Journal of Clinical Oncology 17, 284-292.
  • Bhatia, R., Wayner, E.A., McGlave, P.B. and Verfaillie, C.M. (1994) "Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function", Journal of Clinical Investigation 94, 384-391.
  • Bhatia, R., McGlave, P.B. and Verfaillie, C.M. (1995) "Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha", Journal of Clinical Investigation 96, 931-939.
  • Bhatia, R., McCarthy, J.B. and Verfaillie, C.M. (1996) "Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoiclic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia", Blood 87, 3883-3891.
  • Bhatia, R. and Verfaillie, C.M. (1998) "The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia", Leukemia and Lymphoma 2, 41-254.
  • Pane, F., Mostarda, L. Selleri, C., Salzano, R., Raiola, A.M., Luciano, L., Saglio, G., Rotoli, B. and Salvatore, F. (1999) "BCR/ABL mRNA and the P210(BCR/ABL) protein arc down-modulated by interferon-alpha in chronic myeloid leukemia patients", Blood 94, 2200-2207.
  • Colamonici, O.R., Pfeffer, L., D'Alessandro, F., Platanias, L.C., Rosolen, A., Nordan, R., Cruciani, R.A. and Diaz, M.O. (1992) "Multichain structure of the Interferon alpha-2 receptor on hematopoietic cells", Journal of Immunology 148, 2126-2132.
  • Platanias, L.C., Pfeffer, L.M., Cruciani, R. and Colamonici, O.R. (1993) "Characterization of the a-subunit of the IFNa receptor: Evidence of N- and O-linked glycosylation and association with other surface proteins", Journal of Immunology 150, 7382-3388.
  • Platanias, L.C. Pfeffer, L.M., Barton, K., Vardiman, J.W., Golomb, H.M. and Colamonici, O.R. (1992) "Expression of the IFNa receptor in bairy cell leukemia cells", British Journal of Haematology 82, 541-546.
  • Uzé, G., Lutfalla, G. and Gresser, I. (1990) "Genetic transfer of a functional human Interferon a receptor into mouse cells: cloning and expression of its cDNA", Cell 60, 225-232.
  • Novick, D., Cohen, B. and Rubinstein, M. (1994) "The human interferon a/ß receptor characterization and molecular cloning", Cell 77, 391-400.
  • Lutfalla, G., Holland, S.J., Ginato, E., Monneron, D., Reboul, J., Rogers, N.C., Smith, J.M., Stark, G.R., Gardiner, K., Mogensen, K.E., Kerr, l.M. and Uzé, G. (1995) "Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster", EMBO Journal 14, 5100-5107.
  • Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P. and Colamonici, O.R. (1995) "Cloning and expression of a long form of the beta subunit of the interferon alpha/beta receptor that is required for signaling", Journal of Biological Chemistry 270, 21606-21611.
  • Darnell, Jr., J.E., Kerr, I.M. and Stark, G.R. (1994) "Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins", Science 264, 1415-1420.
  • Darnell, Jr., J.E. (1997) "Stats and gene regulation", Science 277, 1630-1635.
  • Darnell, Jr., J.E. (1998) "Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway", Journal of Interferon and Cytokine Research 18, 549-554.
  • Platanias, L.C. and Fish, E.N. (1999) "Signaling pathways activated by interferons", Experimental Hematology 27, 583-1592.
  • Meinke, A., Barahmand-Pour, F., Wohrl, S., Stoiber, D. and Decker, T. (1996) "Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons", Molecular and Cellular Biology 16, 6937-6944.
  • Sattker, M. and Salgia, R. (1998) "Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells", Leukemia 12, 637-644.
  • Ahmad, S., Alsayed, Y., Druker, B.J. and Platanias, L.C. (1997) "The Type 1 interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein", Journal of Biological Chemistry 272, 29991-29994.
  • Alsayed, Y., Uddin, S., Ahmad, S., Majchrzak, B., Druker, B.J. Fish, E.N. and Platanias, L.C. (2000) "Interferon ? activates the C3G-Rap1 signaling pathway", Journal of Immunology, 164, 1800-1806.
  • Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. and Noda, M. (1989) "A ras-related gene with transformation suppressor activity", Cell 56, 77-84.
  • Kitayama, H., Matsuzaki, T., Ikawa, Y and Noda, M. (1990) "Genetic analysis of the Kirsten-ras-revertant 1 gene:potentiation of its tumor suppressor activity by specific point mutations", Proceedings of the National Academy of Sciences, USA 87, 4284-4288.
  • Cook, S., Rubinfeld, B., Albert, I. and McCormick, F. (1993) "RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts", EMBO Journal 12, 3475-3485.
  • Fish, E.N., Uddin, S., Korkmaz, M., Majchrzak, B., Druker, B.J. and Platanias, L.C. (1999) "Activation of a CrkL-Stat5 signaling complex by Type 1 interferons", Journal of Biological Chemistry 274, 571-573.
  • Oda, A., Wakao, H., Fujihara, M., Ozaki, K., Komatsu, N., Tanaka, S., Ikeda, H., Miyajima, A. and Ikebuchi, K. (2000) "Thrombopoietin and interleukin-2 induce association of CRK with STAT5", Biochemical Biophysical Research Communications 278, 299-305.
  • Schulze, H., Ballmaier, M., Welte, K. and Germeshausen, M. (2000) ''Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets", Experimental Hematology 28, 294-304.
  • Oda, A., Sawada, K., Druker, B.J., Ozaki, K., Takano, H., Koizumi, K. Fukada, Y., Handa, M., Koike, T. and Ikeda, Y. (1998) "Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5 A, and STAT5B in primary cultured human erythroid precursors", Blood 92, 443-451.
  • Du, J., Alsayed, Y. Xin, F., Ackerman, S.J. and Platanias, L.C. (2000) "Engagement of the CrkL adapter in interleukin-5 signaling in cosinophils", Journal of Biological Chemistry 275, 33167-33175.
  • Platanias, L.C. Uddin, S., Bruno, E., Korkmaz., M., Ahmad, S., Alsayed, Y. Van Den Berg, D., Druker, B.J., Wickrema, A. and Hoffman, R (1999) "CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors", Experimental Hematology, 27, 1315-1321.
  • Sattler, M., Salgia, R., Okuda, K., Uemura, N., Durstin, M.A., Pisick, E., Xu, G., Li, J.-L., Prasad, K. and Griffin, J.D. (1996) "The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3/ kinase pathway", Oncogene 12, 839-846.
  • Heaney, C. Kolibaba, K., Bhat, A., Oda, T. Ohno, S., Fanning, S. and Druker, B.J. (1997) "Direct binding of CrkL to BCR-ABL is not required for BCR-ABL transformation", Blood 89, 297-306.
  • Oda, T., Heaney, C., Hagopian, J.R., Okuda, K., Griffin, J.D. and Druker, B.J. (1994) "Crk1 is the major tyrosine-phosphorylated protein in neutrophils from pateints with chronic myelo- genous leukemia", Journal of Biological Chemistry 269, 22925-22928.
  • Nichols, G.L., Raines, M.A., Carlos Vera, J., Lacomis, L., Tempst, P. and Golde, D.W. (1994) "Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells", Blood 84, 2912-2918.
  • Ten Hoeve, J., Arlinghaus, R.B., Qiang Guo, J., Heisterkamp, N. and Groffen, J. (1994) "Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia", Blood 84, 1731-1736.
  • Grumbach, I.M., Mayer, I.A., Uddin, S., Lekmine, F., Majchrzak, B., Yamauchi, H., Fujita, S., Druker, B.J., Fish, K.N. and Platanias, L.C (2001) "Engagement of the CrkL adapter in interferon a signaling in BCR-ABL expressing cells", British Journal of Haematology 112, 327-336.
  • Stadler, M., Chelbi-Alix, M.K., Koken, M.H.M., Nenturini, L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M.-C., Schindler, C. and de The, H. (1995) "Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element", Oncogene 11, 2565-2573.
  • Rhodes, J., York, R.D., Tara, D., Tajinda, K. and Druker, B.J. (1999) "CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells", Experimental Hematology 28, 305-310.
  • Kyriakis, J.M. and Avruch, J. (1996) "Sounding the alarm: protein kinase cascades activated by stress and inflammation", Journal of Biological Chemistry 271, 24313-24316.
  • Schaeffer, H.J. and Weber, M.J. "Mitogen-activated protein kinases: specific messages from ubiquitous messengers", (1999) Molecular and Cellular Biology 19, 2435-2444.
  • Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., Strickler, J.F., McLaughlin, M.M., Siemens, I.R., Fisher, S.M., Livi, G.P., White, J.R., Adams, J.L. and Young, P.R. (1994) "A protein kinase involved in the regulation of inflammatory cytokine biosynthesis", Nature 372, 739-746.
  • Han, J., Lee, J.D., Bibbs, L. and Ulevirch, R.J. (1994) "A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells", Science 265, 808-811.
  • Rouse, J., Cohen, P., Trigon, S., Moronge, M., Alonsos-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A.R. (1994) "A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of small heat shock proteins", Cell 78, 1027-1037.
  • Freshney, K.W., Rawlinson, L., Guedson, F. Jones, H., Cowley, S., Hsuan, J. and Saklatvala, J. (1994) "Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of the Hsp27", Cell 78, 1039-1049.
  • Goebert, M., Cuenda, A., Craxton, M., Jakes, R. and Cohen, P. (1997) "Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6): comparison of its substrate specificity with that of other SAP kinases", EMBO Journal 16, 3563-3571.
  • Brewater, J.L., De, V.T., Dwyer, N.D., Winter, E. and Gustin, M.C. (1993) "An osmosensing signal transduction pathway in yeast", Science 259, 1760-1763.
  • Raingeaud, J., Whitmarsh, A.J., Barrett, T., Derijard, B. and Davis, R.J. (1999) "MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway", Molecular and Cellular Biology 16, 1247-1155.
  • Han, J., Jiang, Y. Li, Z., Kravchenko, V.V. and Ulevitch, R.J. (1997) "Activation of the transcription factor MER2C by the MAP kinase p38 in inflammation", Nature 386, 296-299.
  • Baldassare, J.J., Bi, Y. and Bellone, C.J. (1999) "The role of p38 mitogen-activated protein kinase in IL 1b transcription", Journal of Immunology 162, 5367-5373.
  • Thureauf, D.J., Arnold, N.D., Zechner, D., Handford, D.S., DeMartin, K.M., McDonough, P.M., Prywes, R. and Glembotski, C.C. (1998) "p38 mitogen-activated protein kinase mediates the transcriptional induction of the atrial matriuretic factor gene through a serum response element", Journal of Biological Chemistry 273, 20636-20643.
  • Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W. and Haegeman, G. (1998) "p38 and extracellular signal-regulated kinase milogen-activated protein kinase pathways are required for nuclear factor-kB p65 transactivation mediated by tumor necrosis factor", Journal of Biological Chemistry 273, 3285-3290.
  • Miyazawa, K., Mori, A., Miyata, H., Akahane, M., Ajisawa, Y. and Okudaira, H. (1998) "Regulation of interleukin 1ß-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase", Journal of Biological Chemistry 273, 24832-24838.
  • Zhao, M., New, L., Kravchenko, V.V., Kato, Y. Gram, H., Di Padova, F., Olson, E.N., Ulevitch, R.J. and Han, J. (1999) "Regulation of the MEF2 family of transcription factors by p38", Molecular and Cellular Biology, 19, 21-30.
  • Schafer, C., Ross, S.E., Bragado, M.J., Groblewski, G.E., Ernst, S.A. and Williams, J.A. (1998) "A role for the p38 mitogen-activated protein kinase/Hsp27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini", Journal of Biological Chemistry 273, 24173-24180.
  • Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. (1995) "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis", Scienre 270, 1326-1331.
  • Ichijo, H., Nishida, E., Irie, K., ten Dyke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumato, K., Miyazono, K. and Gotoh, Y. (1997) "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways", Science 275, 90-94.
  • Krumer, J.L., Rao, P.K. and Heidenreich, K.A. (1997) "Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase", Journal of Biological Chemistry 272, 20490-20494.
  • Nagata, Y. Takahashi, N. Davis, R.J. and Tokodoro, K. (1998) "Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced crythroid differentiation", Blood 92, 1859-1869.
  • Alsayed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D.V., Minnucci, S. Bokoch, G. and Platanias, L.C. (2001) "Activation of Rac1 and the p38 Map kinase pathway in response to all-trans-retinoic acid", Journal of Biological Chemistry 272, 4012-4019.
  • Robinson, M.J. and Cobb, M.H. (1997) "Mitogen-activated protein kinase pathways", Current Opinion in Cell Biology 9, 180-186.
  • Derijard, B., Raingeaud, J., Barren, T., Wu, I.-H., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) "Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms", Science 267, 682-685.
  • Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L. and Karin, M. (1995) "Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2", Science 268, 286-290.
  • Sanchez, I.R., Hughes, R.T., Mayer, B.J., Yee, K., Woodgett, J.R., Avruch, J., Kyriakis, J.M. and Zon, L.I. (1994) "Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun", Nature 372, 794-798.
  • Han, J., Lee, J.-D., Jiang. Y., Zhuangjie, L., Feng, L. and Ulevitch, R.J. (1996) "Characterization the structure and function of a novel MAP kinase kinase (MKK6)", Molecular and Cellular Biology 271, 2886-2891.
  • Moriguchi, T., Kuriyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E. and Hagiwara, M. (1996) "A novel kinase cascade mediated by mitogen-activated protein kinase 6 and MKK3", Journal of Biological Chemistry 271, 13765-13769.
  • Stein, B., Brady, H., Yang, M.X., Young, D.B. and Barbosa, M.S. (1996) "Cloning and characterization of MEK6, a novel member of the mitogen activated protein kinase kinase cascade", Journal of Biological Chemistry 271, 11427-11433.
  • Enslen, H., Raingeaud, J. and Davis, R.J. (1998) "Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6", Journal of Biological Chemistry 273, 1741-1748.
  • Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Trie, K., Nishida, E. and Matsumoto, K. (1996) "TAB1: an activator of the TAK-1 MAPKKK in TGF-b signal transduction", Science 272, 1179-1182.
  • Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K. and Nishida, E. (1997) "TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase", Journal of Biological Chemistry 272, 8141-8144.
  • Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E. and Matsumoto, K. (1995) "Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction", Science 270, 2008-2011.
  • Tibbles, L.A., Ing, Y.L., Kiefer, F., Chan, J., Iscove, N., Woodgett, J.R and Lassam, N.J. (1996) "Mlk-3 activates the SAPK/JNK and p3a/RK pathways via SHK1 and MKK3/6", EMBO Journal 15, 7026-7035.
  • Zhang, S., Han, J., Sells, M.A., Chernoff, J., Knaus, U.G., Ulevitch, R.J. and Bokoch, G.M. (1995) "Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1", Journal of Biological Chemistry 270, 23934-23936.
  • Frost, J.A., Xu, S., Butchison, M.R., Marcus, S. and Cobb, M.H. (1996) "Actions of Rho family small G proteins and p21-activated protein kinases on mitopen-activated protein kinase family members", Molecular and Cellular Biology 16, 3707-3713.
  • Uddin, S., Sharma, N., Majchrzak, B., Mayer, I., Lekmine, F., Young, P.R., Bokoch, G.M., Fish, E.N. and Platanias, L.C. (2000) "The Rac1/p38 Map kinase pathway is required for IFNa-dependent transcriptional activation but not serine phosphorylation of Stat-proteins", Journal of Biological Chemistry 275, 27634-27640.
  • Alsayed, Y., Uddin, S., Mahmud, N., Kalvakolanu, D., Minnucci, S., Bokoch, G. and Platanias, L.C. (2001) "Activation of Rac1 and the p38 Map kinase pathway in response to all-trans-retinoic acid", Journal of Biological Chemistry 276, 4012-4019.
  • Uddin, S., Mazchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y. Pine, R., Young, P.R., Fish, E.N. and Platanias, L.C. (1999) "Activation of the p38 Map kinase by Type I IFNs", Journal of Biological Chemistry 274, 30127-30131.
  • Mayer, I.A., Verma, A., Grumbach, I.M., Uddin, S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E.N. and Platanias, L.C. (2001) "The p38 Map kinase pathway mediates the growth inhibitory effects of IFNsa in BCR-ABL expressing cells", Journal of Biological Chemistry 276, 28570-28577.
  • Yanagisawa, K., Yamauchi, H., Kaneko, M., Kohno, H., Hasegawa, H. and Fujita, S. (1998) "Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myclogenous leukemia cell line, KT-1, by interferon-alpha", Blood 91, 641-648.
  • Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. and Talpaz, M. (2001) "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", New England Journal of Medicine 344, 1038-1042.
  • Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C.L. (2001) "Efficacy and safely of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia", New England Journal of Medicine 344, 1031-1037.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.